David Baker, DO


Effect of HbA1c Elevation, Glycemic Control Following Mechanical Thrombectomy: David Baker, DO

The vascular neurologist at Cleveland Clinic provided an overview of a study that assessed the extent HbA1c impacts the relationship between mechanical thrombectomy and poor outcomes. [WATCH TIME: 3 minutes]

Avindra Nath, MD


Human Endogenous Retroviruses and Their Role in ALS: Avindra Nath, MD

The clinical director of the National Institute of Neurological Disorders and Stroke provided context on two recent papers that highlight a reactivation of HERV-K virus in the development of amyotrophic lateral sclerosis. [WATCH TIME: 5 minutes]

Louise Palmer, MA


Need for Improved Access to and Interventions for Mental Health in Multiple Sclerosis: Louise Palmer, MA

The health research assistant at the Shepherd Center discussed the importance of interventions that address mental health for patients with multiple sclerosis, including counseling and support groups. [WATCH TIME: 2 minutes]

Benjamin M. Segal, MD


Differences Between Progressive and Relapsing MS: Benjamin Segal, MD

The chair of the Department of Neurology and the director of the Neuroscience Research Institute at The Ohio State University discussed the takeaways from his lecture at ACTRIMS Forum 2021.

Eric Klawiter, MD, MSc


Takeaways, Highlights From the Institutional Perspectives in Neurology: MS: Eric Klawiter, MD, MSc

The director of the Multiple Sclerosis and Neuromyelitis Optica Unit at Massachusetts General Hospital commented on presentations given at the recent event, as well as key takeaways from his own discussion on novel imaging approaches in multiple sclerosis. [WATCH TIME: 2 minutes]

Jodie Haselkorn, MD


AUPN 2022 Veterans Health Administration Workshop

Glenn Graham, MD, PhD; and Sharyl Martini, MD, PhD, moderate a discussion with 4 clincial experts to advance specialized clinical care, education and research for Veterans with movement disorders, multiple sclerosis, epilepsy and seizures, and headache. [WATCH TIME: 1 hour, 52 minutes]

Lynn Marie Trotti, MD, MSc


New AASM Guideline, Improved Awareness of Sleep Disorders: Lynn Marie Trotti, MD, MSc

The professor of neurology at Emory University School of Medicine spoke on the potential for the new AASM hypersomnolence guideline to educate providers treating patients with sleep disorders.

Christine Lebrun-Frenay, MD, PhD, FAAN


Promising Efficacy of Teriflunomide in Radiologically Isolated Syndrome: Christine Lebrun-Frenay, MD, PhD, FAAN

The head of CRCSEP and coordinator of the Neurosciences Research Unit at Paris City University discussed the positive results of teriflunomide in treating radiologically isolated syndrome, a preclinical stage of multiple sclerosis. [WATCH TIME: 4 minutes]

Peter Marks, MD, PhD


Turning Gene Therapy Into Reality: Peter Marks, MD, PhD

The director of the Center for Biologics Evaluation Research at the FDA provided an overview of the Keynote Address he gave at the 2023 Muscular Dystrophy Association Clinical and Scientific Conference. [WATCH TIME: 3 minutes]

Carsten G. Bönnemann, MD


Gaining a Clearer Picture of Gene Therapy in Neuromuscular Disease: Carsten G. Bönnemann, MD

The senior investigator in the Neuromuscular and Neurogenetic Disorders of Childhood Section at NINDS shared his perspective on the data coming out of neuromuscular research and the promise of genetic medicine. [WATCH TIME: 2 minutes]

Isabella Ciccone, MPH


FDA Clears IND Application for Myogenica’s MyoPAXon in Muscular Dystrophy

Pending positive results from an early-stage trial, a mid-stage study evaluating MyoPAXon’s effect on other targeted muscles and muscle function will be initiated.

Rachel Haines, MA, CCC-SLP, MSCS, CBIS


Improving Post-Relapse Recovery in Multiple Sclerosis With Rehabilitation: Rachel Haines, MA, CCC-SLP, MSCS, CBIS

The neuromuscular and movement disorders speech-language pathologist at Orlando Health discussed strategies in managing the phases of multiple sclerosis for patients and the need for collaborative referral practices. [WATCH TIME: 5 minutes]

Debra Stultz, MD


Unmet Needs in Narcolepsy and Clinical Pearls

Neurology experts discuss the unmet needs in narcolepsy treatment and share clinical pearls from their experiences.

Saar Anis, MD


Ongoing Therapeutic Developments for Movement Disorders: Saar Anis, MD

When asked about developments, the neurologist and movement disorders specialist at Sheba Tel-HaShomer Medical Center in Israel commented on the need to identify disease-modifying therapies. [WATCH TIME: 3 minutes]

Alice Lam, MD, PhD


Increased Risk of Epilepsy in Older Adults and the Growing Population: Alice Lam, MD, PhD

The assistant professor of neurology at Massachusetts General Hospital and Harvard Medical School spoke about the high risk of epilepsy for the older population at the 2022 AES annual meeting. [WATCH TIME: 1 minute]

Larisa Reyderman, PhD


Emerging Tools for Early Detection of Alzheimer Disease

The field of Alzheimer disease has entered a new era of earlier detection, creating an opportunity to redefine treatment and the clinical care of patients.

W. Alex Dalrymple, MD


Gait Dysfunction in Parkinson Disease: The Role of the Cholinergic System

Although combination carbidopa-levodopa has become a standard for the treatment of many of the motor features of PD to this day, gait dysfunction remains a difficult symptom to treat.

Ling Wan-Albert, OTD, OTR/L


The Impact of Social Participation on Cognitive Function in Patients With Parkinson Disease: Ling Wan-Albert, OTD, OTR/L

The assistant professor of occupational therapy at the New York Institute of Technology talked about educating patients with Parkinson disease about the importance of maintaining social participation for cognitive function at ATMRD 2023. [WATCH TIME: 5 minutes]

Andrew Spector, MD


Patient Evaluation for Excessive Daytime Sleepiness

Excessive daytime sleepiness is a hallmark of a number of sleep disorders, and ensuring the proper diagnosis and management of those presenting with it is crucial to care.

Larry Gifford


Illuminating the Night: Understanding Parkinson Nighttime Symptoms

Larry Gifford, a patient living with Parkinson Disease and president of the PD Avengers, discussed sleep issues and nighttime symptoms faced by millions of patients with the disease worldwide.

Sudhir Sivakumaran, PhD


Identifying Impactful Biomarkers of Alzheimer Disease: Sudhir Sivakumaran, PhD; Klaus Romero, MD, MS, FCP

The duo from the Critical Path Institute detailed the thought process behind evaluating the importance of specific biomarkers and their relation to disability progression in Alzheimer disease.

Robin Brey, MD


AUPN Leadership Minute Episode 4: How to Meet With Your Dean

Episode 4 of the AUPN Leadership Minute features Clifton L. Gooch, MD, of the University of South Florida; and Robin Brey, MD, of the University of Texas Health Science Center at San Antonio. [WATCH TIME: 3 minutes]

Brooke Eby


Clinical Benefits to Emphasizing Patient Voices in ALS: Brooke Eby

A patient advocate within the ALS community discussed the importance of incorporating patients and their voices into clinical meetings and trial design to ultimately meet treatment goals. [WATCH TIME: 4 minutes]

Larry B. Goldstein, MD


AUPN Leadership Minute Episode 26: Creating a Formal Junior Faculty Development Plan

Episode 26 of the AUPN Leadership Minute features Tracey A. Milligan, MD, of New York Medical College; and Larry B. Goldstein, MD, of University of Kentucky Medical Center. [WATCH TIME: 8 minutes]

Gonul Ozay, MD


Promising Disease-Modifying Therapies in Parkinson Disease

Despite years of use of gold-standard therapy levodopa, therapeutic development in Parkinson disease has advanced rapidly and expanded to numerous novel pathways and targets.

Albert L. Wright, Jr.


AUPN Leadership Minute Episode 10: What Your CEO Wants From You

Episode 10 of the AUPN Leadership Minute features Mud M Alvi, MD, of West Virginia University and Robert C. Byrd Health; and Albert L. Wright, Jr., the president and CEO of West Virginia University Health System. [WATCH TIME: 4 minutes]

Zoltan Mari, MD


Advice to Physicians for Use of Wearable Devices in PD

Zoltan Mari, MD, shares advice and tips to physicians and patients for the use of wearable devices in PD.

Suzan Khoromi, MD, MHS


Cluster Headache: A Clinical Overview

As the most common trigeminal autonomic cephalalgia, this unilateral and severe headache is accompanied by ipsilateral autonomic features and is often challenging to treat.

© 2024 MJH Life Sciences

All rights reserved.